.Along with early period 1 data now out in the wild, metabolic ailment clothing Metsera is actually ...
.Rivus Pharmaceuticals has actually unveiled the information behind its phase 2 weight problems gain...
.Bristol Myers Squibb is paying Perfect Medicine $110 thousand upfront to develop reagents for ex-bo...
.Novartis has tattooed a bargain likely worth more than $1 billion along with Flagship-founded Gener...
.Lately debuted Metsera is unfolding some phase 1 data for its GLP-1 receptor agonist, showing a 7.5...
.Surrounded by the hereditary medications branches nationality, Flagship Pioneering is actually unve...
.BioAge Labs is eyeing about $180 million in initial earnings coming from an IPO as well as an exclu...
.An effort by Merck & Co. to uncover the microsatellite steady (MSS) metastatic intestines cancer...
.Spain-based Asabys Partners has actually shut a fund of 180 thousand euros ($ 200 thousand), amount...
.BioAge Labs is generating nearly $200 million via its Nasdaq IPO today, with the proceeds set aside...